Nanox Imaging Ltd. (NASDAQ: NNOX), through its subsidiary Nanox AI Ltd., has entered into a distribution agreement with Technologic s.r.l., an Italian company affiliated with Tecnologie Avanzate, to commercialize its AI-powered bone health solution, HealthOST, in Italy. The agreement is a strategic move to expand Nanox AI's commercial presence in the Italian market by leveraging Technologic's experience and local market knowledge. HealthOST analyzes eligible routine CT scans to provide qualitative and quantitative assessments of the spine, helping clinicians identify patients who may benefit from further evaluation for musculoskeletal conditions such as osteoporosis.
This development matters because it represents a tangible step in Nanox's mission to drive the world's transition to preventive health care. By integrating AI into routine imaging workflows, Nanox aims to enable earlier detection of chronic diseases, improve clinical efficiency, and broaden access to care. The partnership with Technologic allows Nanox to tap into the Italian healthcare market, where an aging population and rising incidence of osteoporosis make early detection critical. Osteoporosis is often underdiagnosed until a fracture occurs, and HealthOST's ability to flag at-risk patients from existing CT scans could lead to earlier interventions and better outcomes. Moreover, this agreement demonstrates the commercial viability of Nanox's AI solutions, which are a key component of its end-to-end medical imaging platform.
Nanox's ecosystem includes several innovative components. Nanox.ARC is a cost-effective, 3D multi-source digital tomosynthesis imaging system designed for ease of use and scalability. Nanox.AI, which includes HealthOST, is a suite of AI-based algorithms that augment the interpretation of routine CT imaging to identify early signs often associated with chronic disease. Nanox.CLOUD provides a cloud-based platform for secure data management, storage, and advanced imaging analytics. Additionally, Nanox.MARKETPLACE and USARAD Holdings offer access to remote radiology and cardiology experts and comprehensive teleradiology services, while Nanox Health IT combines deep healthcare IT expertise with leading technology partners to deliver RIS, PACS, AI, dictation, and secure infrastructure solutions that streamline workflows and support safer, more efficient care delivery.
By integrating imaging technology, AI, cloud infrastructure, clinical expertise, a marketplace, and health information technology, Nanox seeks to lower barriers to adoption, improve utilization, and advance preventive care worldwide. The distribution agreement for HealthOST in Italy is a clear indication of how the company plans to execute this vision on a global scale. Investors and industry observers can follow Nanox's progress through its newsroom at http://ibn.fm/NNOX. For the full press release, visit https://ibn.fm/y9Zro.
The announcement was distributed via BioMedWire, a specialized communications platform focused on the biotechnology, biomedical sciences, and life sciences sectors. BioMedWire is one of over 75 brands within the Dynamic Brand Portfolio at IBN, which delivers access to a vast network of wire solutions via InvestorWire, article and editorial syndication to 5,000+ outlets, enhanced press release enhancement, social media distribution, and a full array of tailored corporate communications solutions. This broad reach ensures that news like Nanox's Italian expansion reaches a wide audience of investors, influencers, consumers, journalists, and the general public.
